Teva Pharmaceutical Industries (TEVA)
(Delayed Data from NYSE)
$13.32 USD
-0.11 (-0.82%)
Updated Mar 18, 2024 04:00 PM ET
After-Market: $13.32 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth D Momentum A VGM
Industry / Sector Report
Industry : Medical - Generic Drugs
Zacks Industry Rank
Bottom 28% (183 out of 251)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.60 | 1.42 | 9.99 |
Current Quarter Estimate | 0.51 | 1.25 | 59.00 |
Year Ago Quarter Estimate | 0.40 | -4.28 | 50.37 |
Next Quarter Estimate | 0.58 | 1.37 | 60.00 |
Next Year Estimate | 2.60 | 7.08 | 238.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -7.03 | 18.50 | 20.73 |
Next Year | 9.24 | 13.80 | 13.55 |
Last 5 Years | -4.00 | 0.80 | 9.00 |
Next 5 Years | 3.80 | 8.60 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 5.25 | 1.64 |
Price/Book (MRQ) | 1.85 | 1.07 |
Price/Cash Flow (MRFY) | 3.82 | 10.30 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -3.33% | -3.33% |
Return on Equity (TTM) | 34.90% | 0.14% |
Debt to Equity (MRQ) | 2.23 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.